Dong-A Dapagliflozin 5 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate
Tablet · Prescription medication
Dong-A ST Co., Ltd.
MFDS item code 202300385 · Approved 2023.01.30 · Insurance code 642507740
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be used alone or in combination with other medications. It is particularly applicable for patients who have difficulty controlling blood sugar and have cardiovascular diseases or risk factors. Detailed information on clinical trial results can be found in the professional materials. Overall, this medication helps improve blood sugar control in type 2 diabetes.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. There are no relevant data.
This medication should not be used in certain patients. For example, it is contraindicated in individuals allergic to the active ingredient or excipients, patients with type 1 diabetes, diabetic ketoacidosis, those with lactose intolerance or associated genetic disorders, and patients undergoing dialysis. This medication should be used with caution in patients with inadequate fluid volume or impaired kidney function. This medication may cause hypotension or worsen kidney function, so it is essential to thoroughly check fluid status and kidney function before and during administration. During treatment with this medication, adverse effects such as genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, and diabetic ketoacidosis may occur. Genital infections are reported to occur more frequently in women, and immediate treatment should be sought if symptoms arise. The blood sugar control effectiveness of this medication can vary depending on kidney function and is not recommended for patients with moderate to severe renal impairment. Pregnant or breastfeeding women should avoid using this medication, and it should be discontinued immediately if pregnancy is confirmed. This medication may interact with other drugs, particularly diuretics, insulin, and sulfonylureas, requiring dose adjustments to minimize the risk of hypoglycemia or dehydration. In the case of overdose, no specific antidote exists, so it is important to receive symptomatic care. Furthermore, while taking this medication, the 1,5-anhydroglucitol test for blood sugar monitoring may not be reliable; alternative methods should be used to determine blood glucose levels. This medication does not significantly affect driving or machine operation abilities; however, caution is advised due to the risk of hypoglycemia when taken with insulin or sulfonylureas. Finally, the safety and effectiveness of this medication have not been established in children, so it should not be administered to pediatric patients.
Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, lumbar pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, initial treatment renal creatinine clearance reduction, dyslipidemia, initial treatment serum creatinine elevation, elevated serum urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, bile duct stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, sensory disturbances, cerebral infarction, nerve compression, acute pyelonephritis, chest pain, chronic gastritis, intestinal diverticula, pneumoperitoneum, frequent bowel movements, gastroenteritis, colon polyps, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, urinary stones, abnormal urination, increased blood lactate, lymphocytopenia, vitamin D deficiency, increased appetite, taste disturbances, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, bronchitis, herpes zoster, sinusitis, tonsillitis, herpes simplex, styes, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, heat sensation, influenza-like syndrome, chest pain, fatigue, pain, edema, foreign body sensation, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, irregular menstruation, hair loss, dermatitis, xerosis, allergic dermatitis, contact dermatitis, diabetic foot ulcer, sweating abnormalities eczema, dyshidrotic eczema, eczema, hyperkeratosis, nail discoloration, skin lesions, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, myasthenia, myalgia, osteoarthritis, ligament sprain, dry eye, eye pain, retinal disorders, vision deterioration, blepharitis, cataracts, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid swelling, keratitis, ocular hypertension, visual impairment, vitreous floaters, oral and pharyngeal pain, allergic rhinitis, asthma, voice disorders, nosebleeds, sleep apnea syndrome, wheezing, arteriosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus, anal genital warts, adenoma, neuroma, unspecified pituitary neoplasm, male hypogonadism, thyroid cyst, thyroid nodule, food allergy, polycythemia, dyspepsia, nausea, diarrhea, vomiting, urinary retention, headache, nasopharyngitis, upper respiratory infection, hunger, vaginal discharge, pruritus
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to keep the storage temperature between 1 to 30 degrees Celsius to maintain the medication's effectiveness.
Yellow round film-coated tablets
30 tablets/box[(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Propanediol Hydrate
Tablet · Prescription medication
Dong-A ST Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.